Cellular
nitric oxide (NO) synthesis determines whether NO has cytoprotective or cytotoxic effects at anatomic sites; thus it is important to identify potential
NO synthase isoforms in
tumor tissue and tumor cell lines which might be involved in
tumor development or destruction. Incubation of human pancreatic
adenocarcinoma cell lines (AsPc-1, BxPc-3, CaPan-2) with
cytokines resulted in increased NO formation, indicating the existence of the NOS2
isoform. This was confirmed by
reverse transcriptase-polymerase chain reaction (RT-PCR) and western blot analysis. Furthermore, we identified the presence of the endothelium-derived NOS
isoform 3 by RT-PCR analysis and immunohistochemistry in normal and pancreatic
tumor biopsies. NOS3 was markedly overexpressed in the vasculature of the
tumor tissue. RT-PCR analysis of
tumor biopsies identified NOS
isoform 2
mRNA in 60% of cases, but western blot analysis or immunohistochemistry scored negative for this
isoform. It is noteworthy that the NOS
enzyme activity in pancreatic tumor cell lines and
tumor biopsies was inhibited by
EGTA by approximately 30% and 65%, respectively. Our results suggest that increased endothelium-derived NOS
isoform 3 expression in pancreatic
adenocarcinomas regulates blood flow and is therefore involved in the vascularization and neovascularization of human pancreatic
tumors.